PERIOPERATIVE OUTCOMES OF COMBINED HEART SURGERY AND LUNG TUMOR RESECTION: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/4mmgyc87Keywords:
Heart surgery, Lung tumor resection, Perioperative outcomes, Combined cardiothoracic surgeryAbstract
Background: Cancer and cardiovascular disease are the leading causes of death in both men and women worldwide. There are concerns regarding the potentially increased mortality and complication rates of simultaneous surgery and the adequacy of lung exposure during heart surgery.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of cthe requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 14 articles, whereas the results of our search on
SagePub brought up 91 articles. The results of the search conducted for the last year of 2013 yielded a total 9 articles for PubMed and 23 articles for SagePub. In the end, we compiled a total of 5 papers, 4 of which came from PubMed and 1 of which came from SagePub. We included five research that met the criteria.
Conclusion: In summary, combined heart surgery and lung tumor resection had a low mortality rate and an acceptable complication rate. Subgroup analyses revealed that most patients with lung cancer underwent uncompromised anatomical resection and mediastinal lymph node sampling or dissection during combined cardiothoracic surgery, and showed offpump CABG may reduce the complication rate compared with on-pump CABG. Further researches are still needed to verify these findings.
References
Li Z, Liu B, Ge W, Zhang W, Gu C, Liu J, et al. Effect of simultaneous surgical treatment of severe coronary artery disease and lung cancer. J Int Med Res. 2019;47(2):591–9.
Liu B, Chen C, Gu C, Li Q, Liu J, Pu Y. Combined Coronary Artery Bypass Graft (CABG) Surgery and Lung Resection for Lung Cancer in Patients More than 50 Years-of-Age. Med Sci Monit. 2018;24:3307–14.
Yang Y, Xiao F, Wang J, Song B, Li XH, He ZS, et al. Simultaneous surgery in patients with both cardiac and noncardiac diseases. Patient Prefer Adherence. 2016;10:1251–8.
Šantavý P, Szkorupa M, Bohanes T, Lonský V. Simultaneous cardiac surgery with pulmonary resection. Cor Vasa. 2015 Apr 1;57(2):e82–5.
Yeginsu A, Vayvada M, Karademir BC, Erkilinc A, Tasci AE, Buyukbayrak F, et al. Combined OffPump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease. Braz J Cardiovasc Surg. 2018;33(5):483–9.
Ma X, Huang F, Zhang Z, Song F, Ou S. Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency. J Thorac Dis. 2016;8(8):2038–45.
Kaku R, Teramoto K, Ishida K, Igarashi T, Hashimoto M, Kitamura S, et al. Simultaneous resection of pulmonary tumor following cardiovascular surgery. Asian J Surg. 2017 Apr 1;40(2):123–8.
Kovacicova K, Omran N, Mandak J. Combined surgical treatment of lung cancer and heart diseases. Bratisl lek Listy. 2014;115(12):776–80.
Gaudino M, Angelini GD, Antoniades C, Bakaeen F, Benedetto U. Off‐Pump Coronary Artery Bypass Grafting: 30 Years of Debate. J Am Heart Assoc. 2018;71(6).
Kunz SA, Miles LF, Ianno DJ, Mirowska-Allen KL, Matalanis G, Bellomo R, et al. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass. Perfusion. 2018;33(6):445–52.
Ranucci M, Pistuddi V, Dedda UD, Menicanti L, De Vincentiis C, Baryshnikova E. Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study. Platelets. 2019;30(7):908–14.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
